Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | KIF11 | P52732 | 4/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1810781 | 1.00 | LTA4H (0.55) | LTA4HPRSS1PRSS2PRSS3KIF11 | |
| SCHEMBL1810782 | 0.88 | PRSS1 (0.47) | LTA4HPRSS1PRSS2PRSS3SLC1A3 | |
| SCHEMBL4230862 | 0.85 | SLC1A5 (0.47) | LTA4HKIF11SLC1A3GRM8GRM6 | |
| SCHEMBL2266753 | 0.85 | GRM6 (0.46) | LTA4HKIF11SLC1A3GRM8GRM6 | |
| SCHEMBL28497163 | 0.85 | PRSS1 (0.44) | LTA4HPRSS1PRSS2PRSS3SLC1A3 | |
| SCHEMBL2266748 | 0.85 | GRM6 (0.46) | LTA4HKIF11SLC1A3GRM8GRM6 | |
| SCHEMBL27842369 | 0.84 | LTA4H (0.52) | LTA4HPRSS1PRSS2PRSS3KIF11 | |
| SCHEMBL10306609 | 0.84 | ELANE (0.45) | LTA4HPRSS1PRSS2PRSS3SLC1A3 | |
| SCHEMBL19491916 | 0.83 | LTA4H (0.46) | LTA4HPRSS1PRSS2PRSS3CYP1A2 | |
| SCHEMBL7782888 | 0.82 | ALPI (0.48) | LTA4HPRSS1PRSS2PRSS3KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220016251-A1 | LYMPHATIC MEDIATED TRANSPORT-BASED TRIGLYCERIDE PRODRUG, AND PREPARATION METHOD THEREFOR | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-3919481-A1 | LYMPHATIC MEDIATED TRANSPORT-BASED TRIGLYCERIDE PRODRUG, AND PREPARATION METHOD THEREFOR | Shenyang Pharmaceutical University (CN) | 2021-12-08 | — | — | EP | disclosed |
| WO-2020156307-A1 | LYMPHATIC MEDIATED TRANSPORT-BASED TRIGLYCERIDE PRODRUG, AND PREPARATION METHOD THEREFOR | 沈阳药科大学 | 2020-08-06 | — | — | WO | disclosed |
| EP-0780167-B1 | A method and apparatus for diffusing a chemical solution, a method and apparatus for injecting a liquid, and a method of remedying soil | CANON KK (JP) | 2000-06-07 | — | — | EP | disclosed |
| US-5877390-A | USING GAS PRESSURE | CANON KABUSHIKI KAISHA (JP) | 1999-03-02 | — | — | US | disclosed |
| EP-0780167-A1 | A method and apparatus for diffusing a chemical solution, a method and apparatus for injecting a liquid, and a method of remedying soil | CANON KABUSHIKI KAISHA (JP) | 1997-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016251-A1 | LYMPHATIC MEDIATED TRANSPORT-BASED TRIGLYCERIDE PRODRUG, AND PREPARATION METHOD THEREFOR | MTTP, PNLIP, MGLL | LTA4H 496/4885PRSS1 930/4885PRSS2 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.